A REVIEW OF MONKEY-DUST-DRUG

We subsequently developed a far more distinct probe, [18F]CFA, which was used in the current review to evaluate dCK action in tumors when dealt with with a small molecule dCK inhibitor. This probe is additionally being researched in a clinical demo at our institution To guage changes in dCK activity following cancer immunotherapy 18. PET probes in